Paper27261908
Classification and Pathology of Lung Cancer.
Zheng M. Surg Oncol Clin N Am, 2016. Cited by 276 papers, by iCite.
Cite this record
ConductScience Library. Classification and Pathology of Lung Cancer. Papers, record 27261908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27261908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoid Tumor | Major topic |
| Carcinoma, Neuroendocrine | Major topic |
| Lung Neoplasms | Major topic |
| Neuroendocrine Tumors | Major topic |
| Small Cell Lung Carcinoma | Major topic |
| Humans |
Source PubMed
Cited by201
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 276 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42582931 | Epigenetics in lung cancer precision medicine: from bench to bedside-a narrative review. | Transl Lung Cancer Res | 2026 | https://conductscience.org/library/papers/42582931 | PubMed |
| 42569776 | GNN-EGG: Graph neural network explanations via graph generation. | Neurocomputing (Amst) | 2026 | https://conductscience.org/library/papers/42569776 | PubMed |
| 42548795 | Tumor-associated neutrophils in lung adenocarcinoma: from mechanisms to therapeutic targeting. | Front Immunol | 2026 | https://conductscience.org/library/papers/42548795 | PubMed |
| 42435178 | Targeting Lung Cancer Metabolism: Therapeutic Opportunities and Challenges. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42435178 | PubMed |
| 42415103 | Automated lung cancer classification using intensity-driven RoI selection and transfer learning. | BMC Med Inform Decis Mak | 2026 | https://conductscience.org/library/papers/42415103 | PubMed |
| 42292412 | Tumor-immune crosstalk in lung cancer: emerging roles of long non-coding RNAs. | Front Immunol | 2026 | https://conductscience.org/library/papers/42292412 | PubMed |
| 42193278 | In Vitro Cell Viability and Migration Inhibitory Effects of Isorhamnetin in Non-Small Cell Lung Cancer Cells. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193278 | PubMed |
| 42183023 | Functional role of long non-coding RNA MALAT1 and HOTAIR in lung cancer. | Noncoding RNA Res | 2026 | https://conductscience.org/library/papers/42183023 | PubMed |
| 42147259 | Immunohistochemistry as a Cornerstone in Lung Cancer Diagnosis: Subtyping Based on the 2021 World Health Organization Classification and Its Practical Application. | World J Oncol | 2026 | https://conductscience.org/library/papers/42147259 | PubMed |
| 42012657 | Co-treatment of Colchicine and Rosiglitazone synergistically inhibits cytokine-driven inflammation and modulates the related hsa-miRNA26a-5p, hsa-miRNA21-5p, and STAT3 expression in non-small cell lung cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42012657 | PubMed |
| 42009743 | Hybrid supervised deep learning for lung adenocarcinoma diagnosis to optimize surgical strategies. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42009743 | PubMed |
| 41924446 | Functional significance of miR-218 in lung cancer. | J Cancer Metastasis Treat | 2026 | https://conductscience.org/library/papers/41924446 | PubMed |
| 41877597 | PrPC Glycoprotein Modulates Atmospherically Relevant Artificial Particulate Matter-Induced Development of Lung Cancer in Mice. | Environ Sci Technol | 2026 | https://conductscience.org/library/papers/41877597 | PubMed |
| 41854102 | Altered DNA Methyltransferase Expression in Pulmonary Large-Cell Neuroendocrine Carcinoma: Pilot Experimental Data Targeted DNMT1, DNMT3A, and DNMT3B. | Cancer Rep (Hoboken) | 2026 | https://conductscience.org/library/papers/41854102 | PubMed |
| 41825247 | Three years of chemotherapy tolerance with concurrent Ayurvedic treatment in a metastatic lung adenocarcinoma: A case report. | J Ayurveda Integr Med | 2026 | https://conductscience.org/library/papers/41825247 | PubMed |
| 41685607 | Suppressive role of SCN4B in the epithelial‑mesenchymal transition of lung adenocarcinoma. | Oncol Rep | 2026 | https://conductscience.org/library/papers/41685607 | PubMed |
| 41601785 | P2RY13+ dendritic cells correlate with enhanced antigen presentation and lymphocyte activation in lung adenocarcinoma. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41601785 | PubMed |
| 41465234 | Molecular and System-Level Characterization of MMP12 Suppression in Lung Cancer: A Combined Bioinformatics and Molecular Approach. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465234 | PubMed |
| 41430026 | Detection of circulating tumor cells and microemboli in the blood of lung adenocarcinoma in situ patients case reports. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41430026 | PubMed |
| 41229734 | A bibliometric analysis of research trends and global perspectives on lung large cell neuroendocrine cancer. | J Thorac Dis | 2025 | https://conductscience.org/library/papers/41229734 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27261908
GET https://conductscience.org/api/papers/v1/27261908/cited_by?page=2